Neurofibromatosis type 1 (NF1) is an autosomal dominant disorder characteri
zed by increased incidence of benign and malignant tumors of neural crest o
rigin. Mutations that activate the protooncogene ras, such as Loss of Nf1,
cooperate with inactivating mutations at the p53 tumor suppressor gene duri
ng malignant transformation, One hundred percent of mice harboring null Nf1
and p53 alleles in cis synergize to develop soft tissue sarcomas between 3
and 7 months of age. These sarcomas exhibit Loss of heterozygosity at both
gene loci and express phenotypic traits characteristic of neural crest der
ivatives and human NF1 malignancies.